TY - CHAP M1 - Book, Section TI - SUPRAVENTRICULAR TACHYCARDIA: ATRIAL TACHYCARDIA, ATRIOVENTRICULAR NODAL REENTRY, AND WOLFF-PARKINSON-WHITE SYNDROME A1 - Calkins, Hugh A2 - Fuster, Valentin A2 - Harrington, Robert A. A2 - Narula, Jagat A2 - Eapen, Zubin J. PY - 2017 T2 - Hurst's The Heart, 14e AB - Supraventricular tachycardias (SVTs) include all tachyarrhythmias that either originate from or incorporate supraventricular tissue in a reentrant circuit. The ventricular rate may be the same or less than the atrial rate, depending on the atrioventricular (AV) nodal conduction. The term paroxysmal supraventricular tachycardia (PSVT) refers to a clinical syndrome characterized by a rapid, regular tachycardia with an abrupt onset and termination. Approximately two-thirds of cases of PSVT result from AV nodal reentrant tachycardia (AVNRT). Orthodromic AV reentrant tachycardia (AVRT), which involves an accessory pathway (AP), is the second most common cause of PSVT, accounting for approximately one-third of cases. The term Wolff-Parkinson-White (WPW) syndrome designates a condition comprising both preexcitation and tachyarrhythmias. Atrial tachycardias, which arise exclusively from atrial tissue, account for approximately 5% of all cases of PSVT.1 The purpose of this chapter is to review the mechanism, clinical features, and approach to diagnosis and treatment of patients with AVNRT and AP-mediated tachycardias (including WPW syndrome). Particular attention is focused on reviewing management guidelines developed by the American Heart Association (AHA), American College of Cardiology (ACC), and Heart Rhythm Society (HRS; formerly known as the North American Society of Pacing and Electrophysiology).1 We will also provide a brief overview of atrial tachycardia. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/04/19 UR - accesscardiology.mhmedical.com/content.aspx?aid=1161718472 ER -